Capparelli et al., demonstrated that MAL S180L conferred resistance against Tb in heterozygous individuals, showing that those subjects displayed intermediate levels of IFN-γ, TNF-α or nitric oxide (NO), which helped to control the infection (29). The gene discussed is MAL; the disease is infection.